State Street’s Inhibrx INBX Stock Holding History

State Street’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.7M	Buy	640,458 +89,613	+16%	+$8.98M	﹤0.01%	1737
2026 Q1	$37M	Buy	550,845 +175,884	+47%	+$13M	﹤0.01%	1910
2025 Q4	$29.6M	Buy	374,961 +171,038	+84%	+$11.7M	﹤0.01%	2039
2025 Q3	$6.87M	Sell	203,923 -1,036	-0.5%	-$25.5K	﹤0.01%	2846
2025 Q2	$2.92M	Buy	204,959 +32,055	+19%	+$414K	﹤0.01%	3179
2025 Q1	$2.42M	Sell	172,904 -3,473	-2%	-$47.2K	﹤0.01%	3172
2024 Q4	$2.72M	Buy	176,377 +16,198	+10%	+$247K	﹤0.01%	3213
2024 Q3	$2.51M	Buy	160,179 +11,593	+8%	+$163K	﹤0.01%	3250
2024 Q2	$2.11M	Buy	+148,586	New	+$2.32M	﹤0.01%	3305

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street's INBX Position: Q2 2026 in Review

State Street increased its Inhibrx (INBX) stake by 16% in Q2 2026, buying an estimated $8.98M and bringing the position to 640,458 shares worth $60.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1737.

State Street first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

State Street held 640,458 shares of Inhibrx worth $60.7M as of Q2 2026.
State Street bought 89,613 Inhibrx shares in Q2 2026, an estimated $8.98M.
Inhibrx made up ﹤0.01% of State Street's portfolio in Q2 2026, its #1737 holding.
State Street first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.